首頁 > 市場調查報告書 > 食物/飲料

保健食品

市場調查報告書

商品編碼

1696251

全球維生素和礦物質市場 - 2025 至 2032 年

Global Vitamins and Minerals Market - 2025-2032

出版日期: 2025年03月25日 | 出版商:

DataM Intelligence | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

簡介目錄

2024 年全球維生素和礦物質市場規模達到 226.8 億美元，預計到 2032 年將達到 345.9 億美元，2025-2032 年預測期內的複合年成長率為 5.42%。

人體的多種發育都需要維生素和礦物質。攝取足量的礦物質可以改善情緒並減輕壓力。它們可以強健骨骼、癒合傷口並增強免疫系統。它們還將食物轉化為能量並修復細胞損傷。維生素和礦物質缺乏會削弱免疫系統並導致多種疾病。

年輕人為了實現美學目標的健康意識不斷增強，以及人們對均衡飲食必要性的認知，推動了維生素和礦物質補充劑市場的興起。全球超過 60% 的消費者每天都使用維生素，約 55% 的消費者被說服攝取補充劑以維持健康的生活方式。消費者對優惠的信心和信念以及消費能力的提高為高階品牌在 2022 年及以後的擴張創造了各種機會。

動態的

健康意識不斷增強

維生素缺乏會導致我們身體出現多種疾病。維生素C缺乏會導致壞血病，而維生素A缺乏會導致夜盲症。身體出現肌肉無力和骨骼不適最常見的原因是維生素缺乏。毋庸置疑，如今大量成年人口都在辦公室工作，單靠飲食無法滿足每日的營養需求。同樣，消費者正在採取一種整體的生活方式來提高他們的生活效率。

因此，人們對人類營養和預防性保健意識的增強正在推動全球對維生素和礦物質補充劑的需求。由於忙碌的生活方式和食物準備過程中營養的流失而導致的維生素缺乏症的普遍存在可能會誘使消費者使用維生素和礦物質補充劑。

世界衛生組織（WHO）估計，全球有超過20億人患有微量營養素缺乏症。各年齡層的膳食補充劑使用量增加了 70%。此外，強烈建議孕婦和 40 歲以上的婦女補充維生素和礦物質。營養不良率較高的國家，如塞拉利昂、賴索托、阿富汗和奈及利亞，可能為維生素和礦物質產業帶來潛力。

供應鏈約束和原物料價格波動

全球維生素和礦物質市場的一個主要限制因素是原料價格的波動和供應鏈中斷。維生素和礦物質的生產依賴於抗壞血酸（維生素 C）、生育酚（維生素 E）和各種礦物鹽等關鍵成分，這些成分主要來自中國、印度和其他亞洲國家。

由於監管限制、貿易政策或地緣政治緊張局勢導致的原料供應的任何波動都可能影響全球供應。例如，2023 年，中國對化學品製造實施了更嚴格的環境法規，導致維生素 C 和 B 群維生素的生產成本上升。這導致供應短缺和價格上漲，影響了全球補充劑製造商。

Vitamins and minerals are needed for the body's development in a variety of ways. Mineral intake in sufficient amounts can improve mood and reduce stress levels. They strengthen the bones, heal wounds and boost the immune system. They also convert food to energy and heal cellular damage. Vitamin and mineral deficiencies can weaken the immune system and lead to a variety of disorders.

The growing health consciousness among young people to accomplish aesthetic goals, as well as people's understanding of the necessity of a balanced diet, is driving the rise of the vitamins and mineral supplements market. More than 60% of customers globally use vitamins daily, with approximately 55% persuaded to ingest supplements to maintain a healthy lifestyle. Consumers' confidence and belief in the benefits, as well as improved spending capacity, have created various chances for premium brands to expand in 2022 and beyond.

Dynamic

Growing Health Awareness

Vitamin deficiency causes a variety of ailments in our body. Vitamin C shortage results in scurvy, while vitamin A deficiency causes night blindness. The most prevalent cause of muscle weakness and bone discomfort in the body is vitamin deficiency. Needless to say, with a big adult population working in offices nowadays, a diet alone cannot provide daily nutritional requirements. Similarly, consumers are adopting a holistic lifestyle to increase productivity in their lives.

As a result, people's increased awareness of human nutrition and preventative healthcare is driving up global demand for vitamins and mineral supplements. The prevalence of vitamin deficiencies due to a hectic lifestyle and loss of nutrition during food preparation is likely to tempt consumers to use vitamins and minerals supplements.

The World Health Organization (WHO) estimates that there are over two billion cases of micronutrient deficiency worldwide. Dietary supplement usage has increased by 70% across all age groups. Also, vitamins and mineral supplements are highly suggested for pregnant women and those over the age of 40. Countries with greater malnutrition rates, such as Sierra Leone, Lesotho, Afghanistan and Nigeria, may present a potential for the vitamins and minerals sector.

Supply Chain Constraints and Raw Material Price Volatility

One major restraint in the global vitamins and minerals market is the volatility in raw material prices and supply chain disruptions. The production of vitamins and minerals depends on key ingredients such as ascorbic acid (Vitamin C), tocopherols (Vitamin E) and various mineral salts, which are heavily sourced from China, India and other Asian countries.

Any fluctuations in raw material availability due to regulatory restrictions, trade policies or geopolitical tensions can impact global supply. For example, in 2023, China imposed stricter environmental regulations on chemical manufacturing, leading to higher production costs for Vitamin C and B-complex vitamins. This resulted in supply shortages and price surges, affecting supplement manufacturers worldwide.

Segment Analysis

The global vitamins and minerals market is segmented based on product, distribution channel, form and region.

Multivitamin Capsules in the global market are expected to drive the market.

In 2024, the multivitamin capsules accounted for the largest percentage of the global vitamins and minerals market. Of all the vitamins and minerals, multivitamins are the most commonly ingested. These multivitamin tablets greatly assist the working population in meeting their daily nutritional requirements because the vitamins and minerals in these capsules can successfully relieve stress and depression symptoms. For example, Vitamin B promotes the neurological system to produce stress-relieving chemicals. Consuming enough vitamins and minerals might help the brain function and affect mood. According to a National Institute of Mental Health report, approximately 40% of Americans over the age of 50 take multivitamins.

A recent study found that taking a multivitamin or multimineral supplement on a regular basis or everyday improves cognition in older people over a three-year period. If verified by future investigation, these findings could provide a simple and cost-effective technique to decrease age-related memory loss, according to the researchers.

According to studies published in June 2023 by Brigham and Women's Hospital and Harvard Medical School, a multivitamin experiment showed surprisingly substantial effects on memory as we age. According to the 3,500 participants in the COSMOS-Web Study, who were aged 60 and older, taking a daily multivitamin reduced cognitive aging by 3.1 years compared to those who took placebos. COSMOS's second cognitive experiment, the clinical research, revealed that multivitamins may aid in minimizing memory loss.

Geographical Penetration

Growing Health Consciousness in North America

North America is expected to be the dominant region in the global vitamins and minerals market. The first multivitamin (MV) dietary supplements and multivitamin/mineral (MVM) were created in the early 1940s. MVMs, for example, are popular supplements; it is estimated that one-third of individuals in the United States already take them and one-fourth of children and teenagers do too. In the United States in 2019, MVMs and MVs accounted for 38% of all vitamin and mineral supplement sales and 14% of all supplement purchases. In 2020, the United States sold around US$ 55.7 billion in dietary supplements, with 21.2 billion coming from goods containing vitamins, minerals, or both and 8.0 billion coming from MVMs and MVs.

Multivitamins greatly assist the working population in meeting their daily nutritional requirements since the vitamins and minerals in this multivitamin pill can successfully relieve stress and depression symptoms. For example, vitamin B encourages the neurological system to create stress-relieving chemicals. Consuming vitamins and minerals in a suitable and appropriate method increases brain function and has a favorable effect on mood.

According to a poll performed by the National Institute of Mental Health, 40% of Americans over the age of 50 take multivitamin tablets. North America's healthcare system is progressively emphasizing preventive treatment to decrease the stress on the system. Vitamins and supplements are considered preventive measures, matching with this approach and supporting their use.

Competitive Landscape

The major global players in the market include AMWAY, Lonza Group, BASF SE, Koninklijke DSM N.V., Du Pont, Pfizer Inc., Nutrilo GmbH, AIE Pharmaceuticals, ParkAcre Enterprises and Aland (Jiangsu) Nutraceutical.

Why Choose DataM?

Data-Driven Insights: Dive into detailed analyses with granular insights such as pricing, market shares and value chain evaluations, enriched by interviews with industry leaders and disruptors.
Post-Purchase Support and Expert Analyst Consultations: As a valued client, gain direct access to our expert analysts for personalized advice and strategic guidance, tailored to your specific needs and challenges.
White Papers and Case Studies: Benefit quarterly from our in-depth studies related to your purchased titles, tailored to refine your operational and marketing strategies for maximum impact.
Annual Updates on Purchased Reports: As an existing customer, enjoy the privilege of annual updates to your reports, ensuring you stay abreast of the latest market insights and technological advancements. Terms and conditions apply.
Specialized Focus on Emerging Markets: DataM differentiates itself by delivering in-depth, specialized insights specifically for emerging markets, rather than Product generalized geographic overviews. This approach equips our clients with a nuanced understanding and actionable intelligence that are essential for navigating and succeeding in high-growth regions.
Value of DataM Reports: Our reports offer specialized insights tailored to the latest trends and specific business inquiries. This personalized approach provides a deeper, strategic perspective, ensuring you receive the precise information necessary to make informed decisions. These insights complement and go beyond what is typically available in generic databases.

Target Audience 2024

Manufacturers/ Buyers
Industry Investors/Investment Bankers
Research Professionals
Emerging Companies

1. Methodology and Scope

1.1. Research Methodology
1.2. Research Objective and Scope of the Report

2. Definition and Overview

3. Executive Summary

3.1. Snippet by Product
3.2. Snippet by Distribution Channel
3.3. Snippet by Form
3.4. Snippet by Region

4. Dynamics

4.1. Impacting Factors
- 4.1.1. Drivers
  - 4.1.1.1. Growing Health Awareness
- 4.1.2. Restraints
  - 4.1.2.1. Supply Chain Constraints and Raw Material Price Volatility
- 4.1.3. Opportunity
- 4.1.4. Impact Analysis

5. Industry Analysis

5.1. Porter's Five Force Analysis
5.2. Supply Chain Analysis
5.3. Pricing Analysis
5.4. Regulatory Analysis
5.5. Sustainable Analysis
5.6. DMI Opinion

6. By Product

6.1. Introduction
- 6.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 6.1.2. Market Attractiveness Index, By Product
6.2. Vitamins*
- 6.2.1. Introduction
- 6.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
- 6.2.3. Vitamin A
- 6.2.4. Vitamin B
- 6.2.5. Vitamin C
- 6.2.6. Multivitamin
- 6.2.7. Others
6.3. Minerals
- 6.3.1. Zinc
- 6.3.2. Calcium
- 6.3.3. Others
6.4. Multivitamin/mineral (MVM) supplements

7. By Distribution Channel

7.1. Introduction
- 7.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 7.1.2. Market Attractiveness Index, By Distribution Channel
7.2. Hospital Pharmacy*
- 7.2.1. Introduction
- 7.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
7.3. Retail Pharmacy
7.4. Online Sales
7.5. Others

8. By Form

8.1. Introduction
- 8.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 8.1.2. Market Attractiveness Index, By Form
8.2. Capsules*
- 8.2.1. Introduction
- 8.2.2. Market Size Analysis and Y-o-Y Growth Analysis (%)
8.3. Tablets
8.4. Powder
8.5. Chewable
8.6. Others

9. By Region

9.1. Introduction
- 9.1.1. Market Size Analysis and Y-o-Y Growth Analysis (%), By Region
- 9.1.2. Market Attractiveness Index, By Region
9.2. North America
- 9.2.1. Introduction
- 9.2.2. Key Region-Specific Dynamics
- 9.2.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.2.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.2.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.2.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.2.6.1. US
  - 9.2.6.2. Canada
  - 9.2.6.3. Mexico
9.3. Europe
- 9.3.1. Introduction
- 9.3.2. Key Region-Specific Dynamics
- 9.3.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.3.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.3.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.3.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.3.6.1. Germany
  - 9.3.6.2. UK
  - 9.3.6.3. France
  - 9.3.6.4. Italy
  - 9.3.6.5. Spain
  - 9.3.6.6. Rest of Europe
9.4. South America
- 9.4.1. Introduction
- 9.4.2. Key Region-Specific Dynamics
- 9.4.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.4.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.4.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.4.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.4.6.1. Brazil
  - 9.4.6.2. Argentina
  - 9.4.6.3. Rest of South America
9.5. Asia-Pacific
- 9.5.1. Introduction
- 9.5.2. Key Region-Specific Dynamics
- 9.5.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.5.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.5.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form
- 9.5.6. Market Size Analysis and Y-o-Y Growth Analysis (%), By Country
  - 9.5.6.1. China
  - 9.5.6.2. India
  - 9.5.6.3. Japan
  - 9.5.6.4. Australia
  - 9.5.6.5. Rest of Asia-Pacific
9.6. Middle East and Africa
- 9.6.1. Introduction
- 9.6.2. Key Region-Specific Dynamics
- 9.6.3. Market Size Analysis and Y-o-Y Growth Analysis (%), By Product
- 9.6.4. Market Size Analysis and Y-o-Y Growth Analysis (%), By Distribution Channel
- 9.6.5. Market Size Analysis and Y-o-Y Growth Analysis (%), By Form

10. Competitive Landscape

10.1. Competitive Scenario
10.2. Market Positioning/Share Analysis
10.3. Mergers and Acquisitions Analysis

11. Company Profiles

11.1. AMWAY*
- 11.1.1. Company Overview
- 11.1.2. Product Portfolio and Description
- 11.1.3. Financial Overview
- 11.1.4. Key Developments
11.2. Lonza Group
11.3. BASF SE
11.4. Koninklijke DSM N.V.
11.5. Du Pont
11.6. Pfizer Inc.
11.7. Nutrilo GmbH
11.8. AIE Pharmaceuticals
11.9. ParkAcre Enterprises
11.10. Aland (Jiangsu) Nutraceutical

LIST NOT EXHAUSTIVE